Article
Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorder.
The Journal of clinical psychiatry - 1 May 2007
Findling Robert L, Frazier Thomas W, Youngstrom Eric A, McNamara Nora K, Stansbrey Robert J, Gracious Barbara L, Reed Michael D, Demeter Christine A, Calabrese Joseph R
Abstract excerpt
OBJECTIVE: To determine if divalproex sodium was superior to placebo in the treatment of symptomatic youths who suffer from a bipolar spectrum disorder and who also have a parent with a diagnosis of a bipolar illness. METHOD: Youths, ages 5 to 17 years, meeting DSM-IV criteria for bipolar disorder not otherwise specified (NOS) or cyclothymia who also had at least 1 biological parent with bipolar illness were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.